RDNTRadNet, Inc.

$5B

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$420M+9.5% YoY

Gross Profit

$64M15.2% margin

Operating Income

$24M5.8% margin

Net Income

-$2M-0.4% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$89M

Free Cash Flow

$49M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$1.9B

Stockholders' Equity

$631M

Cash & Equivalents

$343M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$420M	$384M	+9.5%
Gross Profit	$64M	$54M	+17.5%
Operating Income	$24M	$22M	+12.6%
Net Income	-$2M	-$935,000	-98.9%

Revenue Segments

Commercial Insurance1

$232M57%

Medicare1

$96M23%

Capitation Arrangements

$35M9%

Medicaid1

$12M3%

Workers' Compensation/Personal Injury1

$12M3%

Health Care, Patient Service Other

$11M3%

Health Care, Management Service

$6M1%

Health Care, Other

$3M1%

RDNT Q4 2023 Earnings — RadNet, Inc. Revenue & Financial Results | Market Cap Arena